Article
The cellular and molecular heterogeneity of the aggressive non-Hodgkin's lymphomas.
Current opinion in oncology - 1 Sept 1998
Howard O M, Shipp M A
Abstract excerpt
The majority of patients with aggressive non-Hodgkin's lymphomas (NHLs) still die of their disease. Although clinical prognostic factors can be used to characterize a patient's risk profile, these clinical features are likely to be surrogate variables for the intrinsic cellular and molecular heterogeneity of the aggressive NHLs. The purpose of this review is to identify newly described cellular and molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
